## Diagnosis of IgA Vasculitis **Key Point:** Skin biopsy with immunofluorescence showing IgA-dominant deposition is the gold standard and most accessible confirmatory test for IgA vasculitis (formerly Henoch-Schönlein purpura). ### Clinical Presentation Recognition The patient presents with the classic tetrad of IgA vasculitis: - Palpable purpura (lower extremities, buttocks) - Arthralgia/arthritis (knees, ankles) - Renal involvement (hematuria, RBC casts, rising creatinine) - Systemic symptoms (fever, malaise) ### Why Skin Biopsy is the Investigation of Choice | Feature | Skin Biopsy | Renal Biopsy | ANCA Serology | |---------|------------|-------------|---------------| | **Accessibility** | Minimally invasive, bedside | Invasive, requires expertise | Non-invasive | | **Diagnostic yield** | >90% with IgA deposition | Gold standard for renal disease | Negative in IgA vasculitis | | **Timing** | Can be done immediately | Reserved for prognostic/therapeutic decisions | Not diagnostic | | **Risk** | Minimal | Bleeding, infection risk | N/A | **High-Yield:** IgA vasculitis is characterized by **IgA-dominant immune complex deposition** on immunofluorescence. The skin biopsy site should be from affected purpuric lesions or normal-appearing skin adjacent to purpura (both show IgA deposition). ### Immunofluorescence Pattern IgA vasculitis shows: - **Dominant IgA** in vessel walls and glomeruli - **Minimal or absent IgG and IgM** - This distinguishes it from other vasculitides (e.g., ANCA-associated vasculitis shows IgG/IgM, not IgA) **Clinical Pearl:** Renal biopsy, while definitive for assessing glomerulonephritis severity and prognosis, is NOT the initial confirmatory test—it is reserved for patients with significant renal involvement who may require immunosuppressive therapy. **Mnemonic:** **IgA-VAS** = IgA Vasculitis—Assess with **Skin** biopsy first (Immunofluorescence confirms IgA-dominant deposition). [cite:Harrison 21e Ch 319]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.